Screening of Korean Herbal Medicines with Inhibitory Activity on Advanced Glycation End Products (AGEs) Formation (III)
![]() ![]() |
Jeong, Il-Ha
(Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine (KIOM))
Kim, Jong-Min (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine (KIOM)) Jang, Dae-Sik (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine (KIOM)) Kim, Joo-Hwan (Department of Life Science, Kyungwon University) Cho, Jung-Hee (Jeonnam Development Institute for Korea Traditional Medicine) Kim, Jin-Sook (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine (KIOM)) |
1 | Bierhans, A., Hofmann, M. A., Ziegler, R. and Nawroth, P. P. (1998) AGEs and their interaction with AGE-receptor in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res. 37: 586-600 DOI ScienceOn |
2 | Singh, R., Barden, A., Mari, T. and Beilin, L. (2001) Advanced glycation end-products; a review. Diabetologia 44: 129-146 DOI ScienceOn |
3 | Foebes, M. J., Yee, L.T., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. M., Cooper, M. E. and Allen, T. J. (2004) Advanced glycation endproduct interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53: 1813-1823 DOI ScienceOn |
4 | Lee, Y. M., Kim, Y. S., Kim, J. M., Jang, D. S., Kim, J. H., Yoo, J. L. and Kim, J. S. (2008) Screening of Korean traditional herbal medicine with inhibitory activity on advanced glycation end products (AGEs) formation (II). Kor. J. Pharmacogn. 39: 223-227 |
5 | Park, W. Y. (1996) Phenolic compounds from Acer ginnala Maxim. Pharmacogn. 27: 212-218 과학기술학회마을 ScienceOn |
6 | Song, C. Q., Zhang, N., Xu, R. S., Song, G. Q., Sheng, Y. and Hong, S. H. (1982) Studies on the antibacterial constituents of the leaves of Acer ginnala maxim. II. isolation and identification of ginnalin B. ginnalin C and other six compounds. Huaxue Xuebao 40: 1142-1147 |
7 | Nakgawa, T., Yokozawa, T., Kim, Y. A., Kang, K. S. and Tanaka, T. (2005) Activity of wen-pi-tang, and purified constituents of rhei rhizome and glycyrrhizae radix against glucose-mediated protein damage. Am. J. Chin. Med. 33: 817-829 DOI ScienceOn |
8 | Kim, J. M., Jang, D. S., Lee, Y. M., Yoo, J. L., Kim, Y. S., Kim, J. H. and Kim, J. S. (2008) Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha. Chem. Biodivers. 5: 352-356 DOI ScienceOn |
9 | Kim, D. W., Son, K. H., Chang, H. W., Bae, K. H., Kang, S. S. and Kim. H. P. (2004) Anti-inflammatory activity of Sedum kamtshaticum. J. Ethnopharmacol. 90: 409-414 DOI PUBMED ScienceOn |
10 | Oturai, P. S., Christensen, M., Rolin, B., Pedersen, K. E., Mortensen, S. B. and Boel, E. (2002) Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats. Metabolism 49: 996-1000 DOI ScienceOn |
11 | Nakmura, S., Makita, Z., Ishikawa, S., Yasumura, K., Fujii, W., Yanagisawa, K., Kawata, T. and Koike, T. (1997) Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 46: 895-899 DOI ScienceOn |
12 | Ahmed, N. (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21 DOI PUBMED ScienceOn |
13 | Wada, R. and Yagihashi, S. (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann. N. Y. Acad. Sci. 1043: 598-604 DOI ScienceOn |
14 | Brownlee, M. (2005) The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615–1625 DOI PUBMED ScienceOn |
15 | Choi, Y. H., Kim, J. H., Kim, M. J., Han, S. S. and Rim, Y. S. (2000) Antioxidative compounds in leaves of Castanea Crenata S. et Z. Korean J. Medicinal Crop Sci. 8: 373-377 |
16 | Stitt, A., Gardiner, T. A., Anderson, L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, S. A., Chachich, M., Baynes, J. W. and Thorpe, S. R. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51: 2826-2832 DOI ScienceOn |
17 | Huebschmann, A. G., Vlassara, H., Regensteiner, J. G. and Reusch, J. E. B. (2006) Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420-1432 DOI ScienceOn |
18 | Edelstein, D. and Brownlee, M., (1992) Mechanistic studies of advanced glycosylation endproduct inhibition by aminoguanidine. Diabetes 41: 26-29 DOI ScienceOn |
19 | Doggrell, S. A. (2001) ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure. Expert Opin. Investig. Drugs 10: 981-983 DOI ScienceOn |
20 | Matsuda, H., Wang, T., Managi, H and Yoshikawa, M. (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11: 5317-5323 DOI ScienceOn |
21 | Vinson, J. A. and Howard, T. B. (1996) Inhibition of protein glycation and advanced glycation endproducts by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663 DOI ScienceOn |
22 | Peyroux, J. and Sternberg, M. (2006) Advanced glycation end products (AGEs): pharmacological inhibition in diabetes. Pathol. Biol. 54: 405-419 DOI ScienceOn |
23 | Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A. (1986) Aminoguanidine prevents diabetesinduced arterial wall protein cross-linking. Science 232: 1629-32 DOI PUBMED |
24 | Fosmark, D. S., Torjesen, P. A., Kilhovd, B. K., Beng, T. J., Sandvik, L., Hanssen, K. F., Agardh, C. D. and Agardh, E. (2006) Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are assodiated with retinopathy in patients with type 2 diabetes mellitus. Metabolism 55: 232-236 DOI ScienceOn |
25 | Jung, H. A., Yoon, N. Y., Kang, S. S., Kim, Y. S. and Choi, J. S. (2008) Inhibitory activities of prenylated flavonoid from sophora flavescens against aldose reductase and generation of advanced glycation endproducts. J. Pharm. Pharmacol 60: 1227-1236 DOI ScienceOn |
26 | Yokozawa, T., Nakagawa, T. and Terasawa, K. (2001) Effects of oriental medicines on the production of advanced glycation end products. J. Traditional Medicines 18: 107-112 |
27 | Desai, K. and Wu, L. (2007) Methylglyoxal and Advanced glycation end products: new therapeutic horizons? Recent Pat. Cardiovasc. Drug Discov. 2: 89-99 DOI ScienceOn |
28 | Figarola, J. L., Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L. Hardy, J. and Rahbar, S. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. (2003) Diabetologia 46: 1140-1152 DOI ScienceOn |
29 | Jang, D. S., Lee, Y. M., Kim, Y. S. and Kim, J. S. (2006) Screening of Korean traditional herbal medicine with inhibitory activity on advanced glycation end products (AGEs) formation. Kor. J. Pharmacogn. 37: 45-52 |
![]() |